Form:	BBD Team Project Outcomes v1.0

CDE ID	CDE Description
* 2777	Site participant ID (Go To: 422)
* 422	EDRN Site ID (Go To: 423)
* 423	EDRN Protocol ID (Go To: 929)
* 929	EDRN Staff ID of the person who collected the data: (Go To: 1219)
* 1219	Date of contact (MM/DD/YYYY): (Go To: 4012)
* 4012	Diagnosed with LCIS? (Go To: 2636)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 3214)
	N/A (98)
	Unknown (99)
* 3214	Number of subform loops to record 2: (Go To: 3201)
	Permissible Values (value): 1 (1)
	2 (2)
	3 (3)
	4 (4)
* 3201	Line number or identifier 2 (system-generated): (Go To: 4013)
* 4013	Timing of LCIS diagnosis: (Go To: 4014)
	Permissible Values (value): First primary diagnosis (1)
	Recurrence of first primary diagnosis (2)
	Second primary diagnosis (3)
	Recurrence of second primary diagnosis (4)
* 4014	LCIS diagnosis date (MM/YYYY): (Go To: 4015)
* 4015	Pathologic primary LCIS tumor size (cm): (Go To: 2636)
* 2636	Diagnosed with DCIS? (Go To: 2823)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 3144)
	N/A (98)
	Unknown (99)
* 3144	Number of loops: (Go To: 3200)
	Permissible Values (value): 0 (0)
	1 (1)
	2 (2)
	3 (3)
	4 (4)
* 3200	Line number or identifier (system-generated): (Go To: 3417)
* 3417	Timing of DCIS diagnosis: (Go To: 3403)
	Permissible Values (value): First primary diagnosis (1)
	Recurrence of first primary diagnosis (2)
	Second primary diagnosis (3)
	Recurrence of second primary diagnosis (4)
* 3403	DCIS diagnosis date (MM/YYYY): (Go To: 1658)
* 1658	Pathologic primary DCIS tumor size (cm): (Go To: 2823)
* 2823	Diagnosed with breast cancer? (Go To: 1425)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 1333)
	Unknown (99)
* 1333	Date of diagnosis (MM/YYYY): (Go To: 3371)
* 3371	Site of breast condition: (Go To: 3389)
	Permissible Values (value): Left breast (1)
	Right breast (2)
	Bilateral (5)
	Other, specify: (97) (Go To: 3399)
	Unknown (99)
* 3399	Site of invasive breast cancer (Other, specify): (Go To: 3389)
* 3389	Breast quadrant(s) of disease: (Go To: 3388)
	Permissible Values (value): Upper inner (1)
	Upper outer (2)
	Lower inner (3)
	Lower outer (4)
	12:00 (5)
	3:00 (6)
	6:00 (7)
	9:00 (9)
	Central (10)
	Other (95)
	Unknown (99)
* 3388	Is pathology available? (Go To: 1425)
	Permissible Values (value): No (0)
	Yes (1) (Go To: 1643)
	Unknown (99)
* 1643	Histological type (breast): (Go To: 3375)
	Permissible Values (value): Adenoid Cystic (1)
	Ductal (4)
	Lobular (5)
	Papillary (6)
	Micropapillary (7)
	Metaplastic (8)
	Metastatic to breast (9)
	Medullary (10)
	Mucinous (colloid) (11)
	Malignant phyllodes tumor (12)
	Tubular (13)
	Apocrine (14)
	Ductal/Lobular (15)
	Mixed, specify: (16) (Go To: 3416)
	Other, specify: (97) (Go To: 1644)
	Unknown (99)
* 3416	Breast histological type; mixed, specify: (Go To: 3375)
* 1644	Histological type, other specify (breast): (Go To: 3375)
* 3375	Tumor grade: (Go To: 1675)
	Permissible Values (value): Low grade (well differentiated) (1)
	Intermediate grade (moderately differentiated) (2)
	High grade (poorly differentiated) (3)
	High grade (undifferentiated) (4)
	Unknown (99)
* 1675	Final estrogen receptor status diagnosis: (Go To: 1680)
	Permissible Values (value): Positive (1)
	Negative (2)
	Indeterminate (7)
	Unknown (99)
* 1680	Final progesterone receptor status diagnosis: (Go To: 1685)
	Permissible Values (value): Positive (1)
	Negative (2)
	Indeterminate (7)
	Unknown (99)
* 1685	Final diagnosis with HER2/neu: (Go To: 1703)
	Permissible Values (value): Positive (1)
	Negative (2)
	Equivocal (3)
	Unknown (99)
* 1703	Pathologic primary invasive tumor size (cm): (Go To: 1687)
* 1687	Total number of lymph nodes examined : (Go To: 2462)
* 2462	Number of positive nodes: (Go To: 1425)
* 1425	Is participant alive? (Go To: 3409)
	Permissible Values (value): No (0) (Go To: 3408)
	Yes (1)
	Unknown (99)
* 3408	Date of death (MM/YYYY): (Go To: 1097)
* 3409	Date of last contact (MM/YYYY): (Go To: 1097)
1097	Comments (do not include any participant identifiers) (Go To: End of Form)